An integrative analysis to enumerate candidate genes for clinical use in oral cancer
Authors:
- 1 December 2022
- journal article
- research article
- Published by Medknow in Journal of Cancer Research and Therapeutics
- Vol. 18 (Suppl 2) , S182-S190
Abstract
Background: Oral cancer (OC) is the most pernicious sub-site of head and neck tumours with poor prognostic value that is largely ascribed to the lack of ideal biomarkers and therapeutic targets. This fact highlights an urgent need to identify biomarkers that can further aid in OC management. Aim: The aim of this study was to identify a gene panel with a maximum clinical utility for OC. Materials and Methods: Eight eligible datasets were downloaded from the Gene Expression Omnibus Database, containing 320OC samples and 173 normal samples. The data were processed by GeneSpring software to reveal differentially expressed genes between OC tissues and normal tissues in eight individual experiments. Functional enrichment and network analysis were performed using PANTHER and STRING databases for concordant genes (fold change >10; P ≤ 0.05). The selected genes were cross-validated in the cancer genome atlas (TCGA), Oncomine, and KaplanMeier (KM) plotter databases. Results: Totally, 65 concordant genes were identified, including 37 up-regulated genes and 28 down-regulated genes. A 13-gene panel CXCL8, CXCL10, FN1, GBP1, IFIT3, ISG15, MMP1, MMP3, MMP10, OASL, SERPINE1, SPP1, and PLAU was elected from the lists of functionally enriched genes, hub genes, and genes that showed high alterations for mutation, copy number variation, and mRNA expression status in 'Head and Neck Squamous Cell Carcinoma patients (n = 279; TCGA, Nature 2015)'. Further, validation in Oncomine database demonstrated significant over-expression of all elected genes in OC patients across multiple datasets. In addition, out of 13, six genes (CXCL8, CXCL10, FN1, PLAU, SERPINE1, and SPP1) showed significant association with the prognosis of Head and Neck cancer patients (n = 500) in the KM plotter database. Conclusions: Using an integrative analysis, our study investigated and validated a 13-gene panel for OC which can be used to improve current diagnostic, prognostic, and treatment approaches.Keywords
This publication has 37 references indexed in Scilit:
- Prognostication and prediction using gene expression profiling in oesophageal cancerEuropean Journal of Surgical Oncology, 2013
- Direct integration of intensity-level data from Affymetrix and Illumina microarrays improves statistical power for robust reanalysisBMC Medical Genomics, 2012
- Pro-inflammatory Genes as Biomarkers and Therapeutic Targets in Oral Squamous Cell CarcinomaJournal of Biological Chemistry, 2010
- Enhanced Interferon Signaling Pathway in Oral Cancer Revealed by Quantitative Proteome Analysis of Microdissected Specimens Using 16O/18O Labeling and Integrated Two-dimensional LC-ESI-MALDI Tandem MSMolecular & Cellular Proteomics, 2009
- Key Issues in Conducting a Meta-Analysis of Gene Expression Microarray DatasetsPLOS Medicine, 2008
- Gene Expression Profiling Identifies Genes Predictive of Oral Squamous Cell CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2008
- Transcriptomic dissection of tongue squamous cell carcinomaBMC Genomics, 2008
- Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?Nature Reviews Cancer, 2007
- Three small integrin‐binding ligand N‐linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinasesThe FASEB Journal, 2004
- Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysisInternational Journal of Cancer, 2003